Our Bureau NEW DELHI

SWISS drugmaker Roche lost the patent in India for its anti-viral drug, Valcyte, widely used by AIDS patients, after the patent office concluded it did not contain the necessary innovation to qualify for marketing exclusivity, said lawyers involved in the case.